|Articles|April 20, 2020

Contagion Live News Network: Coronavirus Updates for April 20, 2020

A daily round up of COVID-19 news.

Welcome to the Contagion Live News Network, I’m Grant Gallagher and this is a coronavirus update for Monday, April 20^th.

Lockdowns implemented during the COVID-19 pandemic have left producers running out of places to store excess barrels of crude oil, driving prices to eventually drop below zero.

Last Thursday, the White House released a road map for easing social distancing restrictions across the United States.

Many states have begun announcing their own individuated plans for reopeningWisconsin governor Tony Evers released a plan for restarting the state's economy which is intended to be put in action after the state sees a 14-day decline in positive tests for COVID-19 and a 14-day decline in deaths from COVID-19.

There are now more than 2,448,000 cases of COVID-19 worldwide and more than 168,000 deaths.

For other stories relevant to COVID-19 and the latest infectious disease news, visit ContagionLive.com. To track the spread of the pandemic in the United States and abroad, be sure to use the Contagion®  Outbreak Monitor.

For the Contagion Live News Network, I’m Grant Gallagher. Thanks for listening.

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Related to this article

October 25th, 2026

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants

Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.

October 23rd, 2026

Measles Update: October 23, 2026

The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.

October 22nd, 2026

Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE

In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.

October 22nd, 2026

Zelicapavir Shortens RSV Symptoms Despite Missing Primary End Point

Oral zelicapavir cut time to complete RSV symptom resolution by up to 1 week in high-risk adults, but it did not meet its primary end point in a phase 2 trial.

October 16th, 2026

Measles Update: October 16, 2026

The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.

October 13th, 2026

Pennsylvania Coroner Reports Sixth Measles-Related Death

A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.

October 12th, 2026

NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy

The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.